Arthritis suppression by NADPH activation operates through an interferon-β pathway

BMC Biology

Volumn 5, Issue , 2007, Pages

  Olofsson, Peter ^a   Nerstedt, Annika ^a   Hultqvist, Malin ^b   Nilsson, Elisabeth C ^a   Andersson, Sofia ^a   Bergelin, Anna ^a   Holmdahl, Rikard ^b  

^a BIOVITRUM AB   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PHYTOL; PRISTANE; MESSENGER RNA; NEUTROPHIL CYTOSOLIC FACTOR 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TERPENE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION PROFILING; GENETIC POLYMORPHISM; INGUINAL LYMPH NODE; NONHUMAN; RAT; RESPIRATORY BURST; RHEUMATOID ARTHRITIS; ANIMAL; ARTHRITIS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; TISSUE DISTRIBUTION;

AGOUTI; MUS; RATTUS;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ENZYME ACTIVATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INTERFERON-BETA; NADP; NADPH OXIDASE; PHYTOL; RATS; RESPIRATORY BURST; RNA, MESSENGER; TERPENES; TISSUE DISTRIBUTION;

EID: 34249901554     PISSN: None     EISSN: 17417007     Source Type: Journal    
DOI: 10.1186/1741-7007-5-19     Document Type: Article

References (84)

1. Firestein GS Evolving concepts of rheumatoid arthritis Nature 2003 423 6937 356-361 10.1038/nature01661 12748655
2. Gabriel SE The epidemiology of rheumatoid arthritis Rheum Dis Clin North Am 2001 27 2 269-281 10.1016/S0889-857X(05)70201-5 11396092
3. Symmons DP Bankhead CR Harrison BJ Brennan P Barrett EM Scott DG Silman AJ Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: Results from a primary care-based incident case-control study in Norfolk, England Arthritis and rheumatism 1997 40 11 1955-1961 10.1002/art.1780401106
4. MacGregor AJ Snieder H Rigby AS Koskenvuo M Kaprio J Aho K Silman AJ Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins Arthritis and rheumatism 2000 43 1 30-37 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B
5. Bannwarth B Labat L Moride Y Schaeverbeke T Methotrexate in rheumatoid arthritis. An update Drugs 1994 47 1 25-50 7510620
6. Pincus T Marcum SB Callahan LF Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone J Rheumatol 1992 19 12 1885-1894 1294735
7. Feldmann M Development of anti-TNF therapy for rheumatoid arthritis Nat Rev Immunol 2002 2 5 364-371 10.1038/nri802 12033742
8. Ruderman EM Pope RM The evolving clinical profile of abatacept (CTLA4-Ig): A novel co-stimulatory modulator for the treatment of rheumatoid arthritis Arthritis Res Ther 2005 7 Suppl 2 S21-25 10.1186/ ar1688 15833145
9. Lipsky PE van der Heijde DM St Clair EW Furst DE Breedveld FC Kalden JR Smolen JS Weisman M Emery P Feldmann M Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group N Engl J Med 2000 343 22 1594-1602 10.1056/NEJM200011303432202 11096166
10. Weinblatt ME Kremer JM Bankhurst AD Bulpitt KJ Fleischmann RM Fox RI Jackson CG Lange M Burge DJ A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate N Engl J Med 1999 340 4 253-259 10.1056/ NEJM199901283400401 9920948
11. Begovich AB Carlton VE Honigberg LA Schrodi SJ Chokkalingam AP Alexander HC Ardlie KG Huang Q Smith AM Spoerke JM A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis Am J Hum Genet 2004 75 2 330-337 1216068 15208781 10.1086/422827
12. Suzuki A Yamada R Chang X Tokuhiro S Sawada T Suzuki M Nagasaki M Nakayama-Hamada M Kawaida R Ono M Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis Nat Genet 2003 34 4 395-402 10.1038/ ng1206 12833157
13. Tokuhiro S Yamada R Chang X Suzuki A Kochi Y Sawada T Suzuki M Nagasaki M Ohtsuki M Ono M An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis Nat Genet 2003 35 4 341-348 10.1038/ng1267 14608356
14. Olofsson P Holmberg J Tordsson J Lu S Akerstrom B Holmdahl R Positional identification of Ncf1 as a gene that regulates arthritis severity in rats Nat Genet 2003 33 1 25-32 10.1038/ng1058 12461526
15. Ueda H Howson JM Esposito L Heward J Snook H Chamberlain G Rainbow DB Hunter KM Smith AN Di Genova G Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease Nature 2003 423 6939 506-511 10.1038/nature01621 12724780
16. Vingsbo-Lundberg C Nordquist N Olofsson P Sundvall M Saxne T Pettersson U Holmdahl R Genetic control of arthritis onset, severity and chronicity in a model for rheumatoid arthritis in rats Nat Genet 1998 20 4 401-404 10.1038/3887 9843218
17. Nauseef WM Assembly of the phagocyte NADPH oxidase Histochem Cell Biol 2004 122 4 277-291 10.1007/s00418-004-0679-8 15293055
18. Gelderman KA Hultqvist M Holmberg J Olofsson P Holmdahl R T cell surface redox levels determine T cell reactivity and arthritis susceptibility Proceedings of the National Academy of Sciences of the United States of America 2006 103 34 12831-12836 1568933 16908843 10.1073/pnas.0604571103
19. Hultqvist M Holmdahl R Ncf1 (p47phox) polymorphism determines oxidative burst and the severity of arthritis in rats and mice Cell Immunol 2005 233 2 97-101 10.1016/j.cellimm.2005.04.008 15936744
20. Hultqvist M Olofsson P Gelderman KA Holmberg J Holmdahl R A New Arthritis Therapy with Oxidative Burst Inducers PLoS Med 2006 3 9 1564167 16968121
21. Vingsbo C Sahlstrand P Brun JG Jonsson R Saxne T Holmdahl R Pristane-induced arthritis in rats: A new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes Am J Pathol 1996 149 5 1675-1683 1865278 8909256
22. Morey JS Ryan JC Van Dolah FM Microarray validation: Factors influencing correlation between oligonucleotide microarrays and real-time PCR Biological procedures online 2006 8 175-193 1779618 17242735 10.1251/ bpo126
23. Husson A Brasse-Lagnel C Fairand A Renouf S Lavoinne A Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle Eur J Biochem 2003 270 9 1887-1899 10.1046/j.1432-1033.2003.03559.x 12709047
24. Nagasaki A Gotoh T Takeya M Yu Y Takiguchi M Matsuzaki H Takatsuki K Mori M Coinduction of nitric oxide synthase, argininosuccinate synthetase, and argininosuccinate lyase in lipopolysaccharide-treated rats. RNA blot, immunoblot, and immunohistochemical analyses J Biol Chem 1996 271 5 2658-2662 10.1074/jbc.271.5.2658 8576237
25. Liao F Rabin RL Yannelli JR Koniaris LG Vanguri P Farber JM Human Mig chemokine: Biochemical and functional characterization J Exp Med 1995 182 5 1301-1314 10.1084/jem.182.5.1301 7595201
26. Gasperini S Marchi M Calzetti F Laudanna C Vicentini L Olsen H Murphy M Liao F Farber J Cassatella MA Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils J Immunol 1999 162 8 4928-4937 10202039
27. Patel DD Zachariah JP Whichard LP CXCR3 and CCR5 ligands in rheumatoid arthritis synovium Clin Immunol 2001 98 1 39-45 10.1006/clim.2000.4957 11141325
28. Brinckerhoff CE Matrisian LM Matrix metalloproteinases: A tail of a frog that became a prince Nat Rev Mol Cell Biol 2002 3 3 207-214 10.1038/ nrm763 11994741
29. Feinberg MW Jain MK Werner F Sibinga NE Wiesel P Wang H Topper JN Perrella MA Lee ME Transforming growth factor-beta 1 inhibits cytokine-mediated induction of human metalloelastase in macrophages J Biol Chem 2000 275 33 25766-25773 10.1074/jbc.M002664200 10825169
30. Wang Z Zheng T Zhu Z Homer RJ Riese RJ Chapman HA Jr Shapiro SD Elias JA Interferon gamma induction of pulmonary emphysema in the adult murine lung J Exp Med 2000 192 11 1587-1600 10.1084/jem.192.11.1587 11104801
31. Leppert D Lindberg RL Kappos L Leib SL Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis Brain Res Brain Res Rev 2001 36 2-3 249-257 10.1016/ S0165-0173(01)00101-1 11690622
32. Grewal TS Genever PG Brabbs AC Birch M Skerry TM Best5: A novel interferon-inducible gene expressed during bone formation Faseb J 2000 14 3 523-531 10698968
33. Au WC Moore PA LaFleur DW Tombal B Pitha PM Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes J Biol Chem 1998 273 44 29210-29217 10.1074/jbc.273.44.29210 9786932
34. Zhang L Pagano JS IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency Mol Cell Biol 1997 17 10 5748-5757 232423 9315633
35. Taniguchi T Takaoka A The interferon-alpha/beta system in antiviral responses: A multimodal machinery of gene regulation by the IRF family of transcription factors Curr Opin Immunol 2002 14 1 111-116 10.1016/ S0952-7915(01)00305-3 11790540
36. Honda K Yanai H Negishi H Asagiri M Sato M Mizutani T Shimada N Ohba Y Takaoka A Yoshida N IRF-7 is the master regulator of type-I interferon-dependent immune responses Nature 2005 434 7034 772-777 10.1038/nature03464 15800576
37. Graham RR Kozyrev SV Baechler EC Reddy MV Plenge RM Bauer JW Ortmann WA Koeuth T Escribano MF Collaborative Groups TA A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus Nat Genet 2006 38 5 550-555 10.1038/ng1782 16642019
38. Sigurdsson S Nordmark G Goring HH Lindroos K Wiman AC Sturfelt G Jonsen A Rantapaa-Dahlqvist S Moller B Kere J Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus Am J Hum Genet 2005 76 3 528-537 1196404 15657875 10.1086/428480
39. Levy D Larner A Chaudhuri A Babiss LE Darnell JE Jr Interferon-stimulated transcription: Isolation of an inducible gene and identification of its regulatory region Proceedings of the National Academy of Sciences of the United States of America 1986 83 23 8929-8933 387047 3466167 10.1073/pnas.83.23.8929
40. de Veer MJ Sim H Whisstock JC Devenish RJ Ralph SJ IFI60/ISG60/IFIT4, a new member of the human IFI54/IFIT2 family of interferon-stimulated genes Genomics 1998 54 2 267-277 10.1006/geno.1998.5555 9828129
41. Sato M Suemori H Hata N Asagiri M Ogasawara K Nakao K Nakaya T Katsuki M Noguchi S Tanaka N Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction Immunity 2000 13 4 539-548 10.1016/S1074-7613(00)00053-4 11070172
42. Witt PL Marie I Robert N Irizarry A Borden EC Hovanessian AG Isoforms p69 and p100 of 2′,5′-oligoadenylate synthetase induced differentially by interferons in vivo and in vitro J Interferon Res 1993 13 1 17-23 8454907
43. Melen K Keskinen P Ronni T Sareneva T Lounatmaa K Julkunen I Human MxB protein, an interferon-alpha-inducible GTPase, contains a nuclear targeting signal and is localized in the heterochromatin region beneath the nuclear envelope J Biol Chem 1996 271 38 23478-23486 10.1074/ jbc.271.38.23478 8798556
44. Asano A Jin HK Watanabe T Mouse Mx2 gene: Organization, mRNA expression and the role of the interferon-response promoter in its regulation Gene 2003 306 105-113 10.1016/S0378-1119(03)00428-1 12657472
45. Kerkhoff C Klempt M Sorg C Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9) Biochim Biophys Acta 1998 1448 2 200-211 10.1016/S0167-4889(98)00144-X 9920411
46. Ryckman C Vandal K Rouleau P Talbot M Tessier PA Proinflammatory activities of S100: Proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion J Immunol 2003 170 6 3233-3242 12626582
47. Berntzen HB Olmez U Fagerhol MK Munthe E The leukocyte protein L1 in plasma and synovial fluid from patients with rheumatoid arthritis and osteoarthritis Scand J Rheumatol 1991 20 2 74-82 1709519
48. Brun JG Jonsson R Haga HJ Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with inflammatory rheumatic diseases J Rheumatol 1994 21 4 733-738 8035402
49. Baccala R Kono DH Theofilopoulos AN Interferons as pathogenic effectors in autoimmunity Immunol Rev 2005 204 9-26 10.1111/ j.0105-2896.2005.00252.x 15790347
50. Colonna M Krug A Cella M Interferon-producing cells: On the front line in immune responses against pathogens Curr Opin Immunol 2002 14 3 373-379 10.1016/S0952-7915(02)00349-7 11973137
51. Haupl T Krenn V Stuhlmuller B Radbruch A Burmester GR Perspectives and limitations of gene expression profiling in rheumatology: New molecular strategies Arthritis Res Ther 2004 6 4 140-146 464885 15225356 10.1186/ ar1194
52. Devauchelle V Marion S Cagnard N Mistou S Falgarone G Breban M Letourneur F Pitaval A Alibert O Lucchesi C DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targets Genes Immun 2004 5 8 597-608 10.1038/ sj.gene.6364132 15496955
53. Heller RA Schena M Chai A Shalon D Bedilion T Gilmore J Woolley DE Davis RW Discovery and analysis of inflammatory disease-related genes using cDNA microarrays Proceedings of the National Academy of Sciences of the United States of America 1997 94 6 2150-2155 20056 9122163 10.1073/ pnas.94.6.2150
54. Oertelt S Selmi C Invernizzi P Podda M Gershwin ME Genes and goals: An approach to microarray analysis in autoimmunity Autoimmun Rev 2005 4 7 414-422 10.1016/j.autrev.2005.05.004 16137606
55. Lanchbury J Hall M Steer S Progress and problems in defining susceptibility genes for rheumatic diseases Rheumatology (Oxford) 2002 41 4 361-364 10.1093/rheumatology/41.4.361 11961163
56. Batliwalla FM Baechler EC Xiao X Li W Balasubramanian S Khalili H Damle A Ortmann WA Perrone A Kantor AB Peripheral blood gene expression profiling in rheumatoid arthritis Genes Immun 2005 6 5 388-397 10.1038/ sj.gene.6364209 15973463
57. Olsen N Sokka T Seehorn CL Kraft B Maas K Moore J Aune TM A gene expression signature for recent onset rheumatoid arthritis in peripheral blood mononuclear cells Ann Rheum Dis 2004 63 11 1387-1392 10.1136/ ard.2003.017194 15479887
58. Shou J Bull CM Li L Qian HR Wei T Luo S Perkins D Solenberg PJ Tan SL Chen XY Identification of blood biomarkers of rheumatoid arthritis by transcript profiling of peripheral blood mononuclear cells from the rat collagen-induced arthritis model Arthritis Res Ther 2006 8 1 R28 1526586 16507131 10.1186/ar1883
59. van der Pouw Kraan TC Wijbrandts CA van Baarsen LG Voskuyl AE Rustenburg F Baggen JM Ibrahim SM Fero M Dijkmans BA Tak PP Rheumatoid Arthritis subtypes identified by genomic profiling of peripheral blood cells: Assignment of a type I interferon signature in a subpopulation of patients Ann Rheum Dis 2007 17223656
60. Jirholt J Lindqvist AB Holmdahl R The genetics of rheumatoid arthritis and the need for animal models to find and understand the underlying genes Arthritis Res 2001 3 2 87-97 128884 11178115 10.1186/ar145
61. Farber JM A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokines Proceedings of the National Academy of Sciences of the United States of America 1990 87 14 5238-5242 54298 2115167 10.1073/pnas.87.14.5238
62. Flodstrom M Niemann A Bedoya FJ Morris SM Jr Eizirik DL Expression of the citrulline-nitric oxide cycle in rodent and human pancreatic beta-cells: Induction of argininosuccinate synthetase by cytokines Endocrinology 1995 136 8 3200-3206 10.1210/en.136.8.3200 7628352
63. Feldmann M Brennan FM Maini RN Role of cytokines in rheumatoid arthritis Annu Rev Immunol 1996 14 397-440 10.1146/annurev.immunol.14.1.397 8717520
64. Bailey WJ Ulrich R Molecular profiling approaches for identifying novel biomarkers Expert Opin Drug Saf 2004 3 2 137-151 10.1517/ 14740338.3.2.137 15006720
65. Decker T Stockinger S Karaghiosoff M Muller M Kovarik P IFNs and STATs in innate immunity to microorganisms J Clin Invest 2002 109 10 1271-1277 150987 12021240 10.1172/JCI200215770
66. Nguyen H Hiscott J Pitha PM The growing family of interferon regulatory factors Cytokine Growth Factor Rev 1997 8 4 293-312 10.1016/ S1359-6101(97)00019-1 9620643
67. Stark GR Kerr IM Williams BR Silverman RH Schreiber RD How cells respond to interferons Annu Rev Biochem 1998 67 227-264 10.1146/ annurev.biochem.67.1.227 9759489
68. Baechler EC Batliwalla FM Karypis G Gaffney PM Ortmann WA Espe KJ Shark KB Grande WJ Hughes KM Kapur V Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus Proceedings of the National Academy of Sciences of the United States of America 2003 100 5 2610-2615 151388 12604793 10.1073/pnas.0337679100
69. Baechler EC Gregersen PK Behrens TW The emerging role of interferon in human systemic lupus erythematosus Curr Opin Immunol 2004 16 6 801-807 10.1016/j.coi.2004.09.014 15511676
70. Bennett L Palucka AK Arce E Cantrell V Borvak J Banchereau J Pascual V Interferon and granulopoiesis signatures in systemic lupus erythematosus blood J Exp Med 2003 197 6 711-723 10.1084/jem.20021553 12642603
71. Palucka AK Blanck JP Bennett L Pascual V Banchereau J Cross-regulation of TNF and IFN-alpha in autoimmune diseases Proceedings of the National Academy of Sciences of the United States of America 2005 102 9 3372-3377 552921 15728381 10.1073/pnas.0408506102
72. Nacionales DC Kelly KM Lee PY Zhuang H Li Y Weinstein JS Sobel E Kuroda Y Akaogi J Satoh M Type I interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14-tetramethyl-pentadecane (pristane) Am J Pathol 2006 168 4 1227-1240 1606560 16565497 10.2353/ ajpath.2006.050125
73. Tak PP IFN-beta in rheumatoid arthritis Front Biosci 2004 9 3242-3247 15353352
74. Treschow AP Teige I Nandakumar KS Holmdahl R Issazadeh-Navikas S Stromal cells and osteoclasts are responsible for exacerbated collagen-induced arthritis in interferon-beta-deficient mice Arthritis and rheumatism 2005 52 12 3739-3748 10.1002/art.21496
75. van Holten J Pavelka K Vencovsky J Stahl H Rozman B Genovese M Kivitz AJ Alvaro J Nuki G Furst DE A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis Ann Rheum Dis 2005 64 1 64-69 10.1136/ard.2003.020347 15242865
76. Tak PP Hart BA Kraan MC Jonker M Smeets TJ Breedveld FC The effects of interferon beta treatment on arthritis Rheumatology (Oxford) 1999 38 4 362-369 10.1093/rheumatology/38.4.362 10378715
77. Biron CA Interferons alpha and beta as immune regulators - a new look Immunity 2001 14 6 661-664 10.1016/S1074-7613(01)00154-6 11420036
78. Brechard S Bueb JL Tschirhart EJ Interleukin-8 primes oxidative burst in neutrophil-like HL-60 through changes in cytosolic calcium Cell Calcium 2005 37 6 531-540 10.1016/j.ceca.2005.01.019 15862344
79. Foell D Frosch M Sorg C Roth J Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation Clin Chim Acta 2004 344 1-2 37-51 10.1016/j.cccn.2004.02.023 15149869
80. Olofsson P Holmberg J Pettersson U Holmdahl R Identification and isolation of dominant susceptibility loci for pristane-induced arthritis J Immunol 2003 171 1 407-416 12817024
81. Olofsson P Holmdahl R Positional cloning of Ncf1 - a piece in the puzzle of arthritis genetics Scand J Immunol 2003 58 2 155-164 10.1046/ j.1365-3083.2003.01293.x 12869136
82. Holmdahl R Carlsén S Mikulowska A Vestberg M Brunsberg U Hansson A Sundvall M Larsson L Pettersson U Genetic analysis of mouse models for rheumatois arthritis Human Genome Methods ©CRC Press LLC, New York, USA Adolph KW 1998 215-238
83. AppliedBiosystems User Bulletin #2 ABI PRISM 7700 sequence detection system Warrington, UK 1997
84. Laborda J 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO Nucleic Acids Res 1991 19 14 3998 328497 1861990 10.1093/nar/19.14.3998